LEM Surgical AG

Developer of multi-arm robotic systems for hard tissue surgery designed to assist in orthopedic and spine procedures.

Medical Devices
Active
Bern, Switzerland Founded 2021
Website ↗
Last updated 2026-08-24
Total raised
$30.7M
Stage
Founded
2021
Headcount
HQ
Bern, Switzerland
Sector
Medical Devices

About

LEM Surgical AG is a company focused on launching robotic surgery platforms that benefit the healthcare system. They are developing and commercializing a humanoid robotic platform focused on hard tissue surgery (bone & joint) that is innovative, progressive, and valuable. Their flagship product, the Dynamis Robotic Surgical System, is an integrated navigation-based robotic platform with real-time tracking capability for spine surgical procedures. The company aims to transform robotic-assisted hard tissue surgery with state-of-the-art surgical humanoid technology, focusing on precision, adaptability, ease of use, and efficiency to achieve better clinical outcomes, improve patient satisfaction, enhance provider satisfaction, achieve financial sustainability, and advance health equity.

Funding history · 2 rounds · $30.7M total

2024-01
B Round $22.0M
2022-12
A Round $8.7M
★ co-founding team★ external investors★ Simon Michel (Ypsomed Group CEO)

Q&A

What is LEM Surgical AG's primary focus?
LEM Surgical AG is focused on developing and commercializing robotic surgery platforms for hard tissue surgery, specifically spine surgical procedures, with their flagship product being the Dynamis Robotic Surgical System.
When was LEM Surgical AG founded?
LEM Surgical AG was founded in 2021.
What is the total amount of funding LEM Surgical AG has raised to date?
LEM Surgical AG has raised a total of $30,700,000 USD.
When did LEM Surgical AG complete its Series B funding round and how much was raised?
LEM Surgical AG completed a Series B funding round in January 2024, raising $22,000,000 USD.
When did LEM Surgical AG complete its Series A funding round and who were the lead investors?
LEM Surgical AG completed an A Round in December 2022, raising $8,700,000 USD. Lead investors included the co-founding team and Simon Michel (Ypsomed Group CEO).
Who is the CEO and Founder of LEM Surgical AG?
Yossi Bar is the CEO and Founder of LEM Surgical AG, appointed in June 2021.
What is the primary sector of LEM Surgical AG?
LEM Surgical AG's primary sector is Medical Devices.
Who is the Chief Commercial Officer at LEM Surgical AG?
Christopher Prentice was appointed as the Chief Commercial Officer at LEM Surgical AG in October 2023.

Team · 15

Yossi Bar
Founder · Chief Executive Officer
Marco Matulic
Founder · CTO of CAScination AG, Board Member
Simon Michel
Founder · CEO Ypsomed Group, Board Member
Prof. Dr.-Ing. Stefan Weber
Founder · CEO of CAScination AG, Board Member
Prof. Dr. Andreas Raabe
Founder · Advisory Board Member
Chris Prentice
Chief Commercial Officer
Olaf Reich
Chief Financial Officer
Dr. Amir Belson
Chairman of the Board
Dave Demski
Board Member
Alf Grunwald
Board Member
Patrick Schär
CEO TecMed AG, Board Member
Gary Wells
Chairman of the Board for Wells Dairy, Inc., Board Member
Dr. Alon Friedlander
Advisory Board Member
PD Dr. Fabrice Külling
Advisory Board Member
Arnold Vetterli
VP of Operations

Sectors & technology

Primary sector
Medical Devices
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitelemsurgical.com

Identifiers & details

Legal nameLEM Surgical AG
Founded2021

Radar intelligence

Patents

EPO36

Web history (Wayback)

Domainlemsurgical.com